These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36115198)

  • 1. Host cell protein identification in monoclonal antibody high molecular weight species.
    Hu M; Molden R; Hu Y; Huang Y; Qiu H; Li N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1210():123448. PubMed ID: 36115198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
    Huang Y; Molden R; Hu M; Qiu H; Li N
    J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Host Cell Protein Analysis in Monoclonal Antibody Products through Molecular Weight Cutoff Enrichment.
    Chen IH; Xiao H; Daly T; Li N
    Anal Chem; 2020 Mar; 92(5):3751-3757. PubMed ID: 31999105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner.
    Chen IH; Xiao H; Li N
    Anal Biochem; 2020 Dec; 610():113972. PubMed ID: 32979367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of CHO host-cell proteins in monoclonal antibody bioprocessing.
    Oh YH; Mendola KM; Choe LH; Min L; Lavoie AR; Sripada SA; Williams TI; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM
    Biotechnol Bioeng; 2024 Jan; 121(1):291-305. PubMed ID: 37877536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.
    E SY; Hu Y; Molden R; Qiu H; Li N
    J Pharm Sci; 2023 Mar; 112(3):673-679. PubMed ID: 36220394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting product association as a mechanism of host-cell protein persistence in bioprocessing.
    Oh YH; Becker ML; Mendola KM; Choe LH; Min L; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM
    Biotechnol Bioeng; 2024 Apr; 121(4):1284-1297. PubMed ID: 38240126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Host Cell Proteins in Monoclonal Antibody Therapeutics Through Size Exclusion Chromatography.
    Zhao B; Abdubek P; Zhang S; Xiao H; Li N
    Pharm Res; 2022 Nov; 39(11):3029-3037. PubMed ID: 36071355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Column Denaturation-Assisted Native Size-Exclusion Chromatography-Mass Spectrometry for Rapid and In-Depth Characterization of High Molecular Weight Variants in Therapeutic Monoclonal Antibodies.
    Yan Y; Xing T; Liu AP; Zhang Z; Wang S; Li N
    J Am Soc Mass Spectrom; 2021 Dec; 32(12):2885-2894. PubMed ID: 34786946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical characterization of host-cell-protein-rich aggregates in monoclonal antibody solutions.
    Herman CE; Min L; Choe LH; Maurer RW; Xu X; Ghose S; Lee KH; Lenhoff AM
    Biotechnol Prog; 2023; 39(4):e3343. PubMed ID: 37020359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification process.
    Hogwood CE; Tait AS; Koloteva-Levine N; Bracewell DG; Smales CM
    Biotechnol Bioeng; 2013 Jan; 110(1):240-51. PubMed ID: 22806637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated strategy for deep profiling of host cell proteins in downstream processing of therapeutic monoclonal antibodies: Novel approach to isolate and digest host cell proteins.
    Zarei M; Jonveaux J; Razvi A; Jahn M
    Eur J Pharm Biopharm; 2024 Aug; 201():114369. PubMed ID: 38885909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics.
    Jawa V; Joubert MK; Zhang Q; Deshpande M; Hapuarachchi S; Hall MP; Flynn GC
    AAPS J; 2016 Nov; 18(6):1439-1452. PubMed ID: 27450229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive method for profiling host cell proteins by coupling limited digestion to ProteoMiner technology.
    Zhang S; Xiao H; Li N
    Anal Biochem; 2022 Nov; 657():114901. PubMed ID: 36130653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWATH-MS as a strategy for CHO host cell protein identification and quantification supporting the characterization of mAb purification platforms.
    Carvalho SB; Profit L; Krishnan S; Gomes RA; Alexandre BM; Clavier S; Hoffman M; Brower K; Gomes-Alves P
    J Biotechnol; 2024 Mar; 384():1-11. PubMed ID: 38340900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and implications of host-cell protein aggregates in biopharmaceutical processing.
    Oh YH; Becker ML; Mendola KM; Choe LH; Min L; Lee KH; Yigzaw Y; Seay A; Bill J; Li X; Roush DJ; Cramer SM; Menegatti S; Lenhoff AM
    Biotechnol Bioeng; 2023 Apr; 120(4):1068-1080. PubMed ID: 36585356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.
    Li X; An Y; Liao J; Xiao L; Swanson M; Martinez-Fonts K; Pavon JA; Sherer EC; Jawa V; Wang F; Gao X; Letarte S; Richardson DD
    Biotechnol Prog; 2021 May; 37(3):e3128. PubMed ID: 33476097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.
    Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR
    Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products.
    Falkenberg H; Waldera-Lupa DM; Vanderlaan M; Schwab T; Krapfenbauer K; Studts JM; Flad T; Waerner T
    Biotechnol Prog; 2019 May; 35(3):e2788. PubMed ID: 30767403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.